Display Settings:

Format

Send to:

Choose Destination
    South Med J. 2009 Jul;102(7):738-40.

    The development of primary cutaneous adenoid cystic carcinoma in a patient with ankylosing spondylitis treated with etanercept.

    Source

    Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskiçsehir, Turkey.

    Abstract

    The tumor necrosis factor-alpha (TNF-alpha) inhibitors are widely used in the treatment of some autoimmune disorders with promising results. However, their safety has been questioned with multiple postmarketing reports of increased risk for malignancies. The case of a patient with ankylosing spondylitis who developed cutaneous adenoid cystic carcinoma after three years of treatment with anti-TNF-alpha therapy is discussed.

    PMID:
    19488017
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk